News Archive: 2010

April, 27, 2010

Indivumed Achieves ISO-9001:2008 Certification and Offers the First Certified Biobank in the World

ISO norm guarantees highest biospecimen quality for research studies.
Hamburg-based Indivumed GmbH today has achieved ISO-9001:2008 certification. The company, which offers biobank products, clinical data and research services for the development of personalized cancer therapies, is now the world’s first ISO-certified provider of human biospecimens.
“We are very pleased with the certification,” said Hartmut Juhl, CEO of Indivumed. [...]

February 02, 2010

Indivumed to Study the Integrity of Biospecimen Sampling Procedures for the U.S. National Cancer Institute

Analysis of biopsy sampling procedures a prerequisite for the development of future individualized cancer therapies
Hamburg, Germany — Hamburg-based Indivumed GmbH has been awarded a subcontract by SAIC-Frederick, Inc., under its prime contract with the U.S. National Cancer Institute (NCI) to assess the impact of sampling procedures on the integrity of cancer biospecimens and key data [...]


Site developed by Swim Design